The Value "Upgrade": Pre-emptive Due Diligence (TM)XOventure has a track record of increasing companies' value and attractiveness as investment and partnering target through our "pre-emptive due diligence" - a due diligence preparation and rehearsal by a multi-disciplinary team of top experts. Unexpected questions and findings that surface during a due diligence occur far too often and may result in value adjustment or loss of the deal. Most of those can be avoided or mitigated easily by knowing upfront what a potential buyer or investor may look for and find in the company's records.
XOventure's Pre-emptive Due Diligence Process has the power to find and fix any issues relevant to potential collaborators, buyers or investors:
Dedicated senior experts with outstanding international experience
All disciplines within drug and device development in one cross-functional team, leading to a unique multidisciplinary process
Experience from Pharma and investor due diligence
Identification and prioritization of gaps and actions for value enhancement across the disciplines using due diligence methods
Coaching the management team to present and defend their case
A fast and cost-effective way to achieve due diligence excellence in Pharma/investor discussions
A proven value generating step for the individual programs
In sharp contrast to the buyer's due diligence, where identified flaws are mostly not pointed out to the seller, but nevertheless affect the outcome of the deal, we not only share all findings, but provide immediate remedy and/or action plans addressing the gaps.
XOventure's Pre-emptive Due Diligence Process has the power to find and fix any issues relevant to potential collaborators, buyers or investors:
In sharp contrast to the buyer's due diligence, where identified flaws are mostly not pointed out to the seller, but nevertheless affect the outcome of the deal, we not only share all findings, but provide immediate remedy and/or action plans addressing the gaps.
|
| Last Updated on Thursday, 15 September 2011 13:13 |
News
|
Dec 2011: Nov 2011: July 2011: XOventure GmbH May 2011: |
